|
Paxillin regulates genomic networks in prostate cancer [C4-2] |
10.67 |
|
Identification of global XBP1s target gene expression in human prostate cancer cells |
9.7 |
|
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples |
8.03 |
|
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition |
6.69 |
|
Human islets of varying quality: the good, the (not so) bad and the ugly |
5.23 |
|
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) |
4.62 |
|
circNFIB suppresses lymphatic metastasis of pancreatic cancer |
4.39 |
|
Gene expression analysis of dengue-infected cells |
4.38 |
|
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B |
4.29 |
|
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer |
2.81 |
|
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations |
2.69 |
|
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma |
2.66 |
|
AR-independent prostate cancer is sustained through FGF signaling |
2.49 |
|
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma |
2.47 |
|
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) |
2.47 |
|
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness |
2.35 |
|
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] |
2.23 |
|
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator |
2.23 |
|
Dtx3L and Androgen Signaling in Prostate Cancer |
2.21 |
|
Single-nucleotide-resolution mapping of HBV promoters using CAGE |
1.99 |
|
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer |
1.7 |
|
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming |
1.64 |
|
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment |
1.59 |
|
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) |
1.53 |
|
A prostate cancer chromatin interaction map |
1.53 |
|
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] |
1.53 |
|
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation |
1.53 |
|
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma |
1.34 |
|
Be1 and Be2 B cells are transcriptionally distinct |
1.29 |
|
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) |
1.23 |
|
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma |
1.23 |
|
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation |
1.16 |
|
Gene expression profile of multiple myeloma cell lines treated with CB-5083 |
1.14 |
|
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression |
1.06 |
|
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 |
1.06 |
|
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer |
1.05 |
|
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines |
1.04 |
|
Global epigenomic reconfiguration during mammalian brain development |
1.01 |
|
RNAseq analysis of ESRP regulated splicing events in prostate cancer |
0.98 |
|
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin |
0.95 |
|
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns |
0.94 |
|
Tracing Enhancer Networks using Epigenetic Traits (TENET) |
0.92 |
|
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma |
0.85 |
|
RNA-sequencing of human liver tissue |
0.82 |
|
Role for citron kinase in prostate cancer growth |
0.8 |
|
MYCi361 regulates MYC target genes |
0.78 |
|
Paxillin regulates genomic networks in prostate cancer [LNCaP] |
0.73 |
|
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells |
0.72 |
|
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone |
0.65 |
|
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks |
0.59 |
|
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation |
0.59 |
|
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling |
0.58 |
|
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer |
0.58 |
|
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] |
0.58 |
|
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 |
0.55 |
|
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) |
0.55 |
|
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 |
0.53 |
|
NR2F2 study |
0.52 |
|
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] |
0.52 |
|
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma |
0.52 |
|
RNA Sequencing of three pairs of gastric cancer |
0.51 |
|
CD86 regulates a pro-survival signal in myeloma cells |
0.47 |
|
Identification of long noncoding RNAs regulated by p53 |
0.47 |
|
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 |
0.44 |
|
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer |
0.43 |
|
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) |
0.43 |
|
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) |
0.42 |
|
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls |
0.39 |
|
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms |
0.38 |
|
Transcriptional responses of human insulinoma cells to acute cytokine exposure |
0.37 |
|
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) |
0.37 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) |
0.34 |
|
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] |
0.32 |
|
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide |
0.31 |
|
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines |
0.3 |
|
Identification of HOXB13 target genes responsive to BET inhibitors |
0.3 |
|
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma |
0.28 |
|
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] |
0.28 |
|
Bone marrow derived human B cells [normal proB] |
0.28 |
|
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF |
0.28 |
|
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] |
0.28 |
|
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. |
0.26 |
|
Expression profile of MM.1S tumors folloiwing treatment with bortezomib |
0.26 |
|
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome |
0.26 |
|
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression |
0.26 |
|
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation |
0.25 |
|
Expression analysis of genes modulated after knock-down of lncRNA CHROME. |
0.25 |
|
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells |
0.25 |
|
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] |
0.25 |
|
Genome-wide analysis of Dengue virus 2 infected cells |
0.24 |
|
Loss of CREBBP results in gene expression repression in lymphoma cells |
0.24 |
|
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells |
0.24 |
|
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation |
0.23 |
|
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome |
0.23 |
|
Lipid degradation promotes prostate cancer cell survival |
0.22 |
|
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines |
0.22 |
|
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death |
0.21 |
|
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose |
0.21 |
|
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] |
0.21 |
|
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression |
0.21 |
|
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant |
0.21 |
|
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant |
0.21 |
|
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) |
0.21 |
|
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells |
0.21 |
|
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) |
0.2 |
|
Effect of PBK knockdown on C4-2 cell transcriptome |
0.2 |
|
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance |
0.2 |
|
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. |
0.2 |
|
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer |
0.2 |
|
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer |
0.19 |
|
An RNA-centric dissection of host complexes controlling flavivirus infection |
0.18 |
|
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] |
0.18 |
|
Next Generation Sequencing of human SMA and healthy control Motor Neurons |
0.18 |
|
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] |
0.18 |
|
eRNA: A graphic user interface-based tool for RNA sequencing data analysis |
0.18 |
|
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics |
0.17 |
|
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] |
0.17 |
|
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine |
0.17 |
|
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression |
0.17 |
|
Effect of CHKA knockdown on C4-2 cell transcriptome |
0.17 |
|
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans |
0.17 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] |
0.15 |
|
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. |
0.15 |
|
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc |
0.15 |
|
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence |
0.15 |
|
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition |
0.15 |
|
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. |
0.15 |
|
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) |
0.15 |
|
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants |
0.14 |
|
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma |
0.14 |
|
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells |
0.14 |
|
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation |
0.14 |
|
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals |
0.14 |
|
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer |
0.14 |
|
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer |
0.14 |
|
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system |
0.13 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] |
0.13 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] |
0.13 |
|
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth |
0.13 |
|
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome |
0.12 |
|
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG |
0.12 |
|
Differetially expressed genes after hTR overexpression in U2OS cells |
0.12 |
|
RNA-Seq with and without RNase treatment in PCa cell lines |
0.12 |
|
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis |
0.12 |
|
ARID1A and ARID1B loss in HCT116 cells |
0.12 |
|
Characterization of human ILC2 subsets |
0.11 |
|
The expression profiles of GBC liver metastasis |
0.11 |
|
BACH2 in human plasma cell fate decision |
0.11 |
|
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line |
0.11 |
|
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity |
0.11 |
|
TGF-β promotes genomic instability after loss of RUNX3 |
0.11 |
|
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures |
0.1 |
|
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] |
0.1 |
|
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) |
0.1 |
|
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer |
0.1 |
|
Genome-wide chromatin analysis of Ewing sarcoma |
0.1 |
|
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) |
0.1 |
|
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function |
0.1 |
|
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation |
0.1 |
|
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection |
0.09 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) |
0.09 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability |
0.09 |
|
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] |
0.09 |
|
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation |
0.09 |
|
Characterization of the Merkel cell carcinoma miRNome |
0.09 |
|
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation |
0.09 |
|
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells |
0.09 |
|
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells |
0.09 |
|
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx |
0.09 |
|
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains |
0.08 |
|
The MEF2B Regulatory Network |
0.08 |
|
The MEF2B Regulatory Network - RNA-seq data |
0.08 |
|
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth |
0.08 |
|
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes |
0.08 |
|
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways |
0.08 |
|
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells |
0.08 |
|
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus |
0.08 |
|
RNA-seq of YB5 and MCF7 treated with different doses of decitabine |
0.08 |
|
Differential expression of genes in AD169-infected MRC5. |
0.08 |
|
RNA-seq analysis of control and Myc-induced U2OS cells |
0.08 |
|
MHC Transcriptomic landscape at haplotype-specific resolution |
0.08 |
|
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 |
0.08 |
|
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 |
0.08 |
|
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia |
0.08 |
|
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] |
0.08 |
|
CDK4/6 inhibitor resistance in prostate cancer |
0.08 |
|
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain |
0.08 |
|
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer |
0.08 |
|
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] |
0.08 |
|
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] |
0.07 |
|
IRF2 is a master regulator of human keratinocyte stem cell fate |
0.07 |
|
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers |
0.07 |
|
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients |
0.07 |
|
Silencing p300 in MCF7 cells to study expression and alternative splicing |
0.07 |
|
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition |
0.07 |
|
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer |
0.07 |
|
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer |
0.07 |
|
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] |
0.07 |
|
Energy Metabolism during Anchorage-Independence |
0.07 |
|
PRDM1 inhibits proliferation of human colon cancer organoids |
0.07 |
|
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines |
0.07 |
|
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome |
0.07 |
|
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells |
0.07 |
|
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation |
0.07 |
|
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO |
0.07 |
|
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines |
0.07 |
|
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] |
0.07 |
|
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells |
0.06 |
|
HEXIM1 is induced by DHODH inhibition to suppress melanoma |
0.06 |
|
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] |
0.06 |
|
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] |
0.06 |
|
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival |
0.06 |
|
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons |
0.06 |
|
RNA sequencing of human pancreatic cancer cell lines |
0.06 |
|
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes |
0.06 |
|
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] |
0.06 |
|
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression |
0.06 |
|
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma |
0.06 |
|
Functional Haploid Human Oocytes Generated from Polar Body Genomes |
0.06 |
|
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) |
0.06 |
|
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 |
0.06 |
|
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) |
0.06 |
|
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation |
0.06 |
|
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 |
0.06 |
|
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 |
0.06 |
|
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells |
0.06 |
|
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma |
0.06 |
|
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line |
0.05 |
|
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line |
0.05 |
|
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance |
0.05 |
|
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase |
0.05 |
|
Cajal bodies are linked to genome conformation [RNA-Seq] |
0.05 |
|
Cajal bodies are linked to genome conformation |
0.05 |
|
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage |
0.05 |
|
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') |
0.05 |
|
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] |
0.05 |
|
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells |
0.05 |
|
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing |
0.05 |
|
CD95/Fas ligand mRNA is toxic to cells |
0.05 |
|
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy |
0.05 |
|
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy |
0.05 |
|
Region-specific Innate Antiviral Responses of the Human Epididymis |
0.05 |
|
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer |
0.05 |
|
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . |
0.05 |
|
RNA-seq of YB5 cells treated with Proscillaridin A |
0.05 |
|
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons |
0.05 |
|
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells |
0.05 |
|
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade |
0.05 |
|
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] |
0.05 |
|
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner |
0.05 |
|
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers |
0.05 |
|
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes |
0.05 |
|
Hepatitis C virus functionally sequesters miR-122 |
0.05 |
|
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] |
0.05 |
|
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells |
0.05 |
|
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation |
0.05 |
|
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors |
0.04 |
|
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA |
0.04 |
|
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] |
0.04 |
|
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression |
0.04 |
|
Identifying the molecular mode of action of itraconazole in colorectal cancer |
0.04 |
|
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module |
0.04 |
|
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol |
0.04 |
|
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha |
0.04 |
|
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). |
0.04 |
|
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling |
0.04 |
|
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells |
0.04 |
|
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs |
0.04 |
|
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC |
0.04 |
|
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans |
0.04 |
|
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity |
0.04 |
|
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells |
0.04 |
|
Overexpression of NFIB and YBX1 in MCF-7 cells |
0.04 |
|
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 |
0.04 |
|
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 |
0.04 |
|
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner |
0.04 |
|
ML29755 RNA-seq data |
0.04 |
|
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming |
0.04 |
|
The evolution of N6-methyladenosine in primates |
0.04 |
|
Gene expression changes associated with resistance to tagraxofusp (SL-401) |
0.04 |
|
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* |
0.04 |
|
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells |
0.04 |
|
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] |
0.04 |
|
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle |
0.04 |
|
WRN knockout effects upon gene expression in SW48 and OVK18 |
0.04 |
|
Cellular response to hepatitis E virus (HEV) infection |
0.04 |
|
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer |
0.04 |
|
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] |
0.04 |
|
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) |
0.04 |
|
Non-coding regions are the main source of tumor-specific antigens |
0.04 |
|
Non-coding regions are the main source of tumor-specific antigens [human] |
0.04 |
|
HNF1 regulates critical functions of the human epididymis epithelium. |
0.04 |
|
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] |
0.04 |
|
Gene expression profiling in metabolically heterogeneous human lung tumors |
0.04 |
|
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] |
0.04 |
|
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans |
0.04 |
|
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans |
0.04 |
|
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] |
0.04 |
|
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 |
0.04 |
|
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes |
0.04 |
|
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 |
0.04 |
|
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation |
0.03 |
|
Selective suppression of endothelial cytokine production by progesterone receptor |
0.03 |
|
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] |
0.03 |
|
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc |
0.03 |
|
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] |
0.03 |
|
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. |
0.03 |
|
Overexpression and knockdown experiment for circCSNK1G3 |
0.03 |
|
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells |
0.03 |
|
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells |
0.03 |
|
NKX2.2 |
0.03 |
|
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets |
0.03 |
|
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. |
0.03 |
|
An siRNA screen identifies CHD4 as a target for epigenetic therapy |
0.03 |
|
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 |
0.03 |
|
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells |
0.03 |
|
HNRNPM-regulated splicing dependencies in prostate cancer |
0.03 |
|
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] |
0.03 |
|
Paxillin regulates genomic networks in prostate cancer [PC3] |
0.03 |
|
Transposon-based construction of strand-specific RNA-seq libraries |
0.03 |
|
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA |
0.03 |
|
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. |
0.03 |
|
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants |
0.03 |
|
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer |
0.03 |
|
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. |
0.03 |
|
Mediator kinase inhibition further activates super-enhancer-associated genes in AML |
0.03 |
|
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 |
0.03 |
|
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 |
0.03 |
|
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells |
0.03 |
|
RNAseq Analysis in glioblastoma cells treated with Mepazine |
0.03 |
|
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells |
0.03 |
|
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance |
0.03 |
|
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method |
0.03 |
|
Differential gene expression profiles in imatinib-resistant cell lines |
0.03 |
|
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] |
0.03 |
|
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma |
0.03 |
|
miR941 overexpression experiment |
0.03 |
|
Leucegene: ALL sequencing |
0.03 |
|
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A |
0.03 |
|
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] |
0.03 |
|
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer |
0.03 |
|
IDH3a KO RNA-seq |
0.03 |
|
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. |
0.03 |
|
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) |
0.03 |
|
Zone dependent distinctive gene expression profile of the normal human liver tissue |
0.02 |
|
Effect of PRDM11 depletion in U2932 cells |
0.02 |
|
The role of FAM46C in myeloma cells [sequencing] |
0.02 |
|
The role of FAM46C in myeloma cells |
0.02 |
|
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] |
0.02 |
|
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression |
0.02 |
|
Landscape of H3K4me3 in human CD19 cells |
0.02 |
|
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency |
0.02 |
|
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation |
0.02 |
|
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene |
0.02 |
|
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. |
0.02 |
|
Differential effects of estrogen receptor beta isoforms on glioblastoma progression |
0.02 |
|
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma |
0.02 |
|
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown |
0.02 |
|
RNA-Sequencing of HepG2 cells treated with TGFBeta |
0.02 |
|
FOXD3 is a novel tumor suppressor in lung cancer |
0.02 |
|
Gene expression analysis of breast cancer cell-lines |
0.02 |
|
Gene expression and genome-wide location analysis of breast cancer cell-lines |
0.02 |
|
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment |
0.02 |
|
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus |
0.02 |
|
Crizotinib v. DMSO in SW480 cells |
0.02 |
|
Electronic cigarettes |
0.02 |
|
U2AF1 mutations alter splice site recognition in hematological malignancies |
0.02 |
|
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] |
0.02 |
|
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis |
0.02 |
|
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma |
0.02 |
|
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer |
0.02 |
|
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells |
0.02 |
|
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles |
0.02 |
|
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion |
0.02 |
|
Gene expression analysis of human liver progenitor-like cells in culture |
0.02 |
|
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network |
0.02 |
|
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] |
0.02 |
|
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] |
0.02 |
|
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates |
0.02 |
|
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation |
0.02 |
|
circRNA profile in hypopharyngeal cancer |
0.02 |
|
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 |
0.02 |
|
LncRNA-GAS5 negative regulation of YAP-target genes expression |
0.02 |
|
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs |
0.02 |
|
quanTIseq: quantifying immune contexture of human tumors |
0.02 |
|
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer |
0.02 |
|
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] |
0.02 |
|
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq |
0.02 |
|
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma |
0.02 |
|
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) |
0.02 |
|
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes |
0.02 |
|
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 |
0.02 |
|
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation |
0.02 |
|
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing |
0.02 |
|
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) |
0.01 |
|
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) |
0.01 |
|
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells |
0.01 |
|
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] |
0.01 |
|
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) |
0.01 |
|
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells |
0.01 |
|
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells |
0.01 |
|
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] |
0.01 |
|
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases |
0.01 |
|
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture |
0.01 |
|
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] |
0.01 |
|
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. |
0.01 |
|
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production |
0.01 |
|
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo |
0.01 |
|
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations |
0.01 |
|
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile |
0.01 |
|
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells |
0.01 |
|
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells |
0.01 |
|
Control of prostate tumour growth by the long non-coding RNA GHSROS |
0.01 |
|
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains |
0.01 |
|
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture |
0.01 |
|
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] |
0.01 |
|
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding |
0.01 |
|
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing |
0.01 |
|
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells |
0.01 |
|
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells |
0.01 |
|
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide |
0.01 |
|
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling |
0.01 |
|
Genome-wide analysis of the Integrator complex (HTS) |
0.01 |
|
Genome-wide analysis of the Integrator complex |
0.01 |
|
Global response to chemotherapy-induced apoptosis |
0.01 |
|
An acquired vulnerability of drug resistant melanoma with therapeutic potential |
0.01 |
|
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat |
0.01 |
|
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel |
0.01 |
|
The cytokine environment influence on human skin-derived T cells |
0.01 |
|
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 |
0.01 |
|
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 |
0.01 |
|
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis |
0.01 |
|
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing |
0.01 |
|
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify |
0.01 |
|
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] |
0.01 |
|
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast |
0.01 |
|
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide |
0.01 |
|
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq |
0.01 |
|
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells |
0.01 |
|
Investigate A2M treatment on human prostate cancer xenograft in mice |
0.01 |
|
Investigate A2M treatment on human prostate cancer and mouse liver |
0.01 |
|
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements |
0.01 |
|
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] |
0.01 |
|
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach |
0.01 |
|
CircRNAome diversity in human mature B-cells, T-cells and monocytes |
0.01 |
|
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease |
0.01 |
|
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection |
0.01 |
|
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq |
0.01 |
|
Transcriptome analysis upon C6orf203 silencing |
0.01 |
|
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny |
0.01 |
|
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells |
0.01 |
|
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) |
0.01 |
|
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. |
0.01 |
|
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. |
0.01 |
|
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients |
0.01 |
|
The role of m6A/m-RNA methylation in stress response regulation |
0.01 |
|
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival |
0.01 |
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells |
0.01 |
|
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits |
0.01 |
|
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) |
0.0 |
|
KSDM1b Role in Ewing Sarcoma |
0.0 |
|
RNA-Seq of Breast and Ovarian Cancer Cell Lines |
0.0 |
|
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. |
0.0 |
|
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells |
0.0 |
|
ARID1A and ARID1B loss in HCT116 and TOV21G cells |
0.0 |
|
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types |
0.0 |
|
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy |
0.0 |
|
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells |
0.0 |
|
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model |
0.0 |
|
Genome-wide mapping of TEL-AML1 targets in acute leukemia |
0.0 |
|
RNA-seq analyisis of PUM2 knockout cells |
0.0 |
|
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 |
0.0 |
|
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells |
0.0 |
|
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation |
0.0 |
|
Androgen Receptor-regulated genes in prostate cancer cells |
0.0 |
|
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells |
0.0 |
|
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers |
0.0 |
|
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence |
0.0 |
|
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 |
0.0 |
|
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI |
0.0 |
|
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] |
0.0 |
|
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function |
0.0 |
|
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] |
0.0 |
|
Co-regulation of splicing by Rbfox1 and hnRNP M |
0.0 |
|
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] |
0.0 |
|
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects |
0.0 |
|
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells |
0.0 |
|
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer |
0.0 |
|
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits |
0.0 |
|
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] |
0.0 |
|
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling |
0.0 |
|
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor |
0.0 |
|
BASP1 modifies the Tamoxifen response |
0.0 |
|
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs |
0.0 |
|
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] |
0.0 |
|
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway |
0.0 |
|
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers |
0.0 |
|
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells |
0.0 |
|
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells |
0.0 |
|
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins |
-0.0 |